The Cancer Advisor

Cancer patients are increasingly inquiring about the use of the anthelmintic drugs Fenbendazole (FenBen) and Ivermectin (IVM) as potential treatments for cancer. Notably, these patients typically fall into two distinct groups, neither of which represents the usual stage 1 or 2 cancer cases where conventional therapies often show promise. The first group consists of older men whose lung or prostate cancer has recurred. Having undergone conventional treatments previously without success, they express skepticism about its effectiveness this time around. The second, larger group comprises younger patients under 40 dealing with aggressive breast cancer, colorectal cancer, or lymphoma—forms of early-onset cancers that appear to lack the typical mutations observed in traditional cases. This article aims to delve into the differences between Fenbendazole and Ivermectin by examining their mechanisms of action, approved uses, and the latest research on their efficacy across various medical con...

Tired of hearing conflicting information about cancer and supplements? Read this guide to uncover the facts. The journey to understanding cancer prevention and treatment is often clouded by mixed messages, particularly regarding diet, lifestyle, and dietary supplements. With a dizzying array of options and claims, it’s easy to question their effectiveness. Without solid scientific evidence, their true impact remains uncertain. Can foods and diet influence your risk of getting cancer? What types of foods reduce your risk and types that might increase your risk? What about vitamin and mineral supplements? Can supplements reduce your cancer risk or do they actually increase your cancer risk?  The term anti-cancer supplements can be a little misleading. Some supplements may help reduce a person’s risk of developing cancer or support the body during cancer treatment. This arti...